Literature DB >> 8431521

Interleukin-9 stimulates the proliferation of enriched human erythroid progenitor cells: additive effect with GM-CSF.

M R Schaafsma1, J H Falkenburg, N Duinkerken, J Van Snick, J E Landegent, R Willemze, W E Fibbe.   

Abstract

In the study we report here we investigated the colony-stimulating activities of interleukin-9 (IL-9). In the presence of erythropoietin, IL-9 was found to stimulate the proliferation of relatively early erythroid progenitor cells (BFU-E) from normal human bone marrow cells depleted of mononuclear phagocytes and T lymphocytes. Neutralization experiments demonstrated that the observed BFU-E-stimulating effect was not the result of intermediate production of IL-3 or GM-CSF by residual accessory cells in response to IL-9. Accordingly, the effects of IL-9 were preserved when cell suspensions were further depleted of accessory cells using CD34 enrichment of progenitor cells. Furthermore, IL-9 did not stimulate bone marrow mononuclear cells to express mRNA for IL-3, GM-CSF, EPA (erythroid-promoting activity), or IL-4, as determined by a cDNA-PCR method. IL-9 is likely to act on a subpopulation of IL-3-responsive erythroid progenitor cells that are not stimulated by GM-CSF, since plateau concentration of IL-9 and GM-CSF had additive effects on BFU-E formation, whereas a combination of IL-9 and IL-3 did not. In addition to its burst-promoting activity, IL-9 was found to have a modest stimulatory activity on myeloid progenitor cells (CFU-GM) in some experiments, suggesting that this effect may be donor related.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8431521     DOI: 10.1007/bf01737688

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  23 in total

1.  Expression and modulation of specific, high affinity binding sites for erythropoietin on the human erythroleukemic cell line K562.

Authors:  J K Fraser; F K Lin; M V Berridge
Journal:  Blood       Date:  1988-01       Impact factor: 22.113

2.  Mast cell growth-enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGFIII (interleukin 9).

Authors:  L Hültner; C Druez; J Moeller; C Uyttenhove; E Schmitt; E Rüde; P Dörmer; J Van Snick
Journal:  Eur J Immunol       Date:  1990-06       Impact factor: 5.532

3.  Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity.

Authors:  C Uyttenhove; R J Simpson; J Van Snick
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

4.  Interleukin-1 synergizes with granulocyte-macrophage colony-stimulating factor on granulocytic colony formation by intermediate production of granulocyte colony-stimulating factor.

Authors:  M R Schaafsma; J H Falkenburg; N Duinkerken; J Van Damme; B W Altrock; R Willemze; W E Fibbe
Journal:  Blood       Date:  1989-11-15       Impact factor: 22.113

5.  Human P40 T-cell growth factor (interleukin-9) supports erythroid colony formation.

Authors:  R E Donahue; Y C Yang; S C Clark
Journal:  Blood       Date:  1990-06-15       Impact factor: 22.113

6.  Two neutralizing monoclonal antibodies against human granulocyte-macrophage colony-stimulating factor recognize the receptor binding domain of the molecule.

Authors:  C B Brown; C E Hart; D M Curtis; M C Bailey; K Kaushansky
Journal:  J Immunol       Date:  1990-03-15       Impact factor: 5.422

7.  Cytokine production by the bladder carcinoma cell line 5637: rapid analysis of mRNA expression levels using a cDNA-PCR procedure.

Authors:  J G Kaashoek; R Mout; J H Falkenburg; R Willemze; W E Fibbe; J E Landegent
Journal:  Lymphokine Cytokine Res       Date:  1991-06

8.  Activities of four purified growth factors on highly enriched human hematopoietic progenitor cells.

Authors:  A Strife; C Lambek; D Wisniewski; S Gulati; J C Gasson; D W Golde; K Welte; J L Gabrilove; B Clarkson
Journal:  Blood       Date:  1987-05       Impact factor: 22.113

9.  Cloning and characterization of a cDNA for a new mouse T cell growth factor (P40).

Authors:  J Van Snick; A Goethals; J C Renauld; E Van Roost; C Uyttenhove; M R Rubira; R L Moritz; R J Simpson
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

10.  Autonomous growth and tumorigenicity induced by P40/interleukin 9 cDNA transfection of a mouse P40-dependent T cell line.

Authors:  C Uyttenhove; C Druez; J C Renauld; M Hérin; H Noël; J Van Snick
Journal:  J Exp Med       Date:  1991-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.